• Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login
Menu
  • Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Serum autoantibodies in patients with age-related macular degeneration (AMD): influence of the response to the intravitreal ranibizumab treatment

Author: Christina Korb (Germany)

Co-authors: Sabine Beck, Norbert Pfeiffer, Franz Grus

Purpose

Anti-retinal autoantibodies could play an important role in the pathogenesis of AMD. Therefore, we evaluated the serum immunoreactivities in patients with exsudative AMD and different responses to the intravitreal ranibizumab treatment.

Setting/Venue

Department of Ophthalmology, University Medical Center, Johannes-Gutenberg University Mainz, Germany.

Methods

IgG Immunreactivities were analysed in patients suffering from dry AMD (n=20), patients with treatment-naive exsudative AMD (n=29), patients with previously treated exsudative AMD and new activity (n=21) and healthy volunteers (n=21). In the group of exsudative AMD patients, serum samples were collected at baseline and after 4, 6 and 12 months, the serum was analysed by customized antigen microarrays containing 61 antigens. The statistical analysis was performed by univariate and multivariate analysis of variance, predictive data-mining methods and artificial neuronal networks were used to detect specific autoantibody patterns.

Results

Patients with exsudative AMD were divided into those showing vision loss of more than 3 lines, no change of vision ≤3 lines or vision improvement of more than 3 lines after the 12 months treatment with ranibizumab. Highly significant changes could be observed between those immunreactivities from patients showing an improvement of vision during ranibizumab treatment and the reduced responders. Significant differences could be observed between the groups, e.g. immunoreactivities against PRG2 (p≤0,0077), Prealbumin (p≤0,0031) und Gamma-Synuclein (p≤0,0026) were up-regulated in patients improving vision and down-regulated in the group of patients that lost more than three lines of vision after one year. Immunoreactivities against D GNB1 (p≤0,021), TUBB3 (p≤0,022), ATP Synthase (p≤00,011) and PolyRp2 (p≤0,000006) were down-regulated in patients improving vision and upregulated in the group of patients with vision loss.

Conlusions

We report a microarray-based evaluation of serum in patients with exsudative AMD after one year of intravitreal ranibizumab treatment and different response to treatment. Significant differences in immunoreactivities between the groups with different response to treatment were observed for nine antigens associated with cellular growth and proliferation. A potential immunoproteomic prediction of response to treatment might be possible in the future.

Financial Disclosure

none

Comments

-

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building 
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2023 Amsterdam

EURETINA Innovation Summit (EIS)

Abstract Viewer

Ophthalmologica

Forum

Opportunities

Memberships

About

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2022 All rights reserved

  • Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login